🇺🇸 FDA
Pipeline program

Ramelteon, triazolam, and placebo (56 possible combinations total)

01-02-TL-375-015

Phase 2 small_molecule completed

Quick answer

Ramelteon, triazolam, and placebo (56 possible combinations total) for Drug Abuse is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Drug Abuse
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials